Figures (1)  Tables (1)

    • Figure 1. 

      The consultation process in the smoking cessation clinic.

    • Characteristic Sample PPAR at 1-month PPAR at 3-month
      N (%) OR (95%CI) p value OR p value
      Overall abstinent rate 3,167 (100%) 26.5 26.1
      Demographic characteristics
      Age group < 18 276 (8.7%) 1 1
      18–24 2,891 (91.3%) 0.895 (0.660–1.213) 0.474 1.127 (0.822–1.543) 0.458
      Gender Male 3,000 (94.7%) 1 1
      Female 167 (5.3) 1.339 (0.950–1.888) 0.095 1.035 (0.725–1.476) 0.851
      Education status Primary school or below 80 (2.5%) 1 1
      High school 1,378 (43.5%) 1.281 (0.710–2.310) 0.411 1.056 (0.603–1.849) 0.849
      College degree or above 1,709 (54.0%) 1.390 (0.771–2.505) 0.273 1.297 (0.742–2.268) 0.361
      Occupational status Active 1,206 (38.1%) 1 1
      Inactive 1,961 (61.9%) 0.891 (0.752–1.056) 0.183 1.074 (0.906–1.273) 0.408
      Smoking status
      Nicotine dependence group (score) 0–3 (low) 1,951 (61.6%) 1 1
      4–6 (moderate) 913 (28.8%) 0.936 (0.778–1.126) 0.484 1.089 (0.907–1.308) 0.359
      ≥ 7 (high) 303 (9.6%) 0.488 (0.351–0.680) < 0.001 0.684 (0.500–0.935) 0.017
      Past-year quit attempts None 1,942 (61.3%) 1 1
      1–5 times 1,097 (34.6%) 0.763 (0.640–0.910) 0.003 0.879 (0.739–1.045) 0.144
      > 5 times 128 (4.0%) 0.825 (0.537–1.268) 0.380 0.698 (0.447–1.090) 0.114
      Willingness to quit Within 30 d 2,402 (75.8%) 1 1
      30 d later 765 (24.2%) 0.398 (0.317–0.500) <0.001 0.457 (0.367–0.569) < 0.001
      Intervention
      Exhaled carbon monoxide test No 2,008 (63.4%) 1 1
      Yes 1,159 (36.6%) 1.401 (1.182–1.660) < 0.001 1.212 (1.023–1.437) 0.027
      Intervention methods Counseling 2,771 (87.5%) 1 1
      First-line medication and counseling 289 (9.1%) 1.354 (1.025–1.788) 0.033 1.094 (0.824–1.451) 0.535
      TCM and counseling 107 (3.4%) 0.821 (0.511–1.320) 0.416 0.902 (0.569–1.429) 0.660

      Table 1. 

      Baseline characteristics and predictors of abstinence rates at 1- and 3-month follow-ups of patients visiting SCCs in China, 2019–2023.